Eledon Pharmaceuticals (ELDN) Institutional Ownership

$2.06
+0.04 (+1.98%)
(As of 04/26/2024 ET)

Institutional Ownership Changes (13F Filings) for Eledon Pharmaceuticals (NASDAQ:ELDN)

Current
Institutional Ownership
Percentage
56.77%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$3.43M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$68.12K
Get ELDN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eledon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ELDN Institutional Buying and Selling by Quarter

Eledon Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2024Armistice Capital LLC2,189,000$3.94M0.1%+20.0%9.045%
11/15/2023Armistice Capital LLC1,824,000$2.50M0.0%-1.0%7.538%
10/19/2023Jmac Enterprises LLC58,041$80K0.0%-27.5%0.246%
8/15/2023BVF Inc. IL4,326,710$5.93M0.2%+86.0%18.372%
8/11/2023SVB Financial Group18,025$25K0.0%-33.1%0.080%
7/20/2023Jmac Enterprises LLC80,041$110K0.0%+46.8%0.356%
2/9/2023CM Management LLC234,800$535K0.6%-4.2%1.706%
11/14/2022Cormorant Asset Management LP1,223,500$3.38M0.2%-6.3%8.894%
11/14/2022Point72 Asset Management L.P.375,000$1.04M0.0%-12.5%2.726%
11/14/2022Boothbay Fund Management LLC22,050$61K0.0%-36.3%0.160%
11/4/2022CM Management LLC245,000$676K0.8%+8.9%1.781%
8/16/2022Woodline Partners LP516,675$1.26M0.0%-23.2%3.755%
5/9/2022CM Management LLC225,000$887K0.7%+95.7%1.636%
4/25/2022Bailard Inc.27,600$109K0.0%N/A0.193%
2/14/2022Point72 Asset Management L.P.431,435$1.90M0.0%+105.9%3.016%
2/11/2022Ensign Peak Advisors Inc77,100$340K0.0%+966.7%0.539%
2/7/2022Ameritas Advisory Services LLC24,219$107K0.0%N/A0.169%
2/2/2022CM Management LLC115,000$507K0.4%+53.3%0.804%
11/16/2021Two Sigma Advisers LP115,900$716K0.0%+48.0%0.810%
11/16/2021Two Sigma Investments LP115,324$713K0.0%+100.5%0.806%
11/16/2021BVF Inc. IL1,363,435$8.43M0.3%+22.5%9.530%
11/15/2021Point72 Asset Management L.P.209,490$1.30M0.0%+11.0%1.464%
11/15/2021Eversept Partners LP114,008$705K0.1%N/A0.797%
11/15/2021Ensign Peak Advisors Inc7,228$45K0.0%-80.0%0.051%
11/10/2021Mercer Global Advisors Inc. ADV16,726$103K0.0%N/A0.117%
8/18/2021Ikarian Capital LLC350,000$2.77M0.2%+40.0%2.446%
8/17/2021Woodline Partners LP857,445$6.78M0.1%-3.8%5.993%
8/17/2021Boothbay Fund Management LLC40,052$317K0.0%+39.6%0.280%
8/16/2021Point72 Asset Management L.P.188,690$1.49M0.0%+51.0%1.319%
8/16/2021Morgan Stanley851,004$6.73M0.0%+7,235.6%5.948%
8/16/2021State Street Corp32,935$261K0.0%N/A0.230%
8/13/2021Renaissance Technologies LLC21,107$167K0.0%-22.0%0.148%
8/13/2021Northern Trust Corp32,116$254K0.0%+106.8%0.224%
8/13/2021Geode Capital Management LLC124,614$985K0.0%+25.7%0.871%
8/13/2021Vanguard Group Inc.209,750$1.66M0.0%-8.8%1.466%
5/19/2021Logos Global Management LP224,071$2.40M0.2%N/A1.566%
5/18/2021BVF Inc. IL1,113,435$11.91M0.4%N/A7.782%
5/18/2021Millennium Management LLC14,588$156K0.0%N/A0.102%
5/18/2021Point72 Asset Management L.P.125,000$1.34M0.0%N/A0.874%
5/18/2021Cormorant Asset Management LP1,415,500$15.15M0.3%N/A9.894%
The Next Step of Their Control Is Here … (Ad)

Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.

4 simple steps to protect your privacy and money before it’s too late.
5/18/2021Citadel Advisors LLC25,062$268K0.0%N/A0.175%
5/17/2021Woodline Partners LP891,055$9.53M0.2%N/A6.228%
5/17/2021EcoR1 Capital LLC1,115,721$11.94M0.5%N/A7.798%
5/17/2021Janus Henderson Group PLC213,899$2.25M0.0%N/A1.495%
5/17/2021Ikarian Capital LLC250,000$2.68M0.1%N/A1.747%
5/13/2021Renaissance Technologies LLC27,051$289K0.0%N/A0.189%
5/12/2021Northern Trust Corp15,528$166K0.0%N/A0.109%
5/12/2021Geode Capital Management LLC99,123$1.06M0.0%N/A0.693%
5/12/2021CM Management LLC75,000$803K0.6%N/A0.524%
5/7/2021BlackRock Inc.12,282$131K0.0%N/A0.086%
4/21/2021Ingalls & Snyder LLC51,149$547K0.0%N/A0.358%
(Data available from 1/1/2016 forward)

ELDN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELDN shares?

During the previous two years, 9 institutional investors and hedge funds held shares of Eledon Pharmaceuticals. The most heavily invested institutionals were BVF Inc. IL ($5.93M), Armistice Capital LLC ($3.94M), Cormorant Asset Management LP ($3.38M), Woodline Partners LP ($1.26M), Point72 Asset Management L.P. ($1.04M), CM Management LLC ($535K), and Jmac Enterprises LLC ($80K).Learn more on ELDN's institutional investors.

What percentage of Eledon Pharmaceuticals stock is owned by institutional investors?

56.77% of Eledon Pharmaceuticals stock is owned by institutional investors. Learn more on ELDN's institutional investor holdings.

Which institutional investors have been buying Eledon Pharmaceuticals stock?

The following institutional investors have purchased Eledon Pharmaceuticals stock in the last 24 months: BVF Inc. IL ($2M), Armistice Capital LLC ($365K), CM Management LLC ($130K), and Jmac Enterprises LLC ($25.50K).

How much institutional buying is happening at Eledon Pharmaceuticals?

Institutional investors have bought a total of 2,520,503 shares in the last 24 months. This purchase volume represents approximately $3.92M in transactions.

Which Eledon Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Eledon Pharmaceuticals stock in the last 24 months: Woodline Partners LP ($156.46K), Cormorant Asset Management LP ($81.60K), Point72 Asset Management L.P. ($53.36K), Jmac Enterprises LLC ($22K), Armistice Capital LLC ($18.80K), Boothbay Fund Management LLC ($12.58K), and CM Management LLC ($10.20K).

How much institutional selling is happening at Eledon Pharmaceuticals?

Institutional investors have sold a total of 363,918 shares in the last 24 months. This volume of shares sold represents approximately $880.34K in transactions.


This page (NASDAQ:ELDN) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners